6 September 2019 News
Johnson & Johnson subsidiary Janssen has announced the European Commission (EC) has approved Stelara (ustekinumab) for patients with moderately to severely active ulcerative colitis (UC).
5 September 2019 Comment
Traffic to top type 2 diabetes websites tends to spike when major cardiovascular outcomes studies are presented
Visits to the Eli Lilly’s Trulicity (dulaglutide) brand site spiked massively in June 2019, bringing it to the top position by a landslide, despite a lack of digital display advertising...
28 August 2019 News
Pharmaceutical company Zogenix has signed a definitive agreement to buy Modis Therapeutics in a deal worth approximately $400m, including an upfront payment of $250m.
26 July 2019 News
Eli Lilly has secured the US Food and Drug Administration (FDA) approval for its Baqsimi nasal powder to be used as an emergency treatment for severe hypoglycaemia.
11 July 2019 Comment
The partnership between Amicus and Paragon will focus on the development of a manufacturing platform for adeno-associated viruses.
8 July 2019 News
Merck Research Laboratories and the University of Utah Health have shown that deactivation of the dihydroceramide desaturase 1 (DES1) enzyme could offer a potential drug target for metabolic diabetes.
28 June 2019 News
Vivus has amended its manufacturing and supply agreement with Nordmark Arzneimittel for Pancreaze (pancrelipase) delayed-release capsules covering an initial term of ten years.
27 June 2019 News
Clinigen Group has secured marketing authorisations from the Medicines and Healthcare Products Regulatory Agency (MHRA) for Melatonin 1mg/ml oral solution and Melatonin 3mg film-coated tablets.
26 June 2019 News
AbbVie has signed a definitive transaction agreement to acquire Irish Botox maker Allergan in a cash and stock transaction valued at around $63bn.